Nektar Therapeutics said it would release topline data from a study of its atopic dermatitis treatment rezpegaldesleukin on Tuesday. Shares climbed 27% to $12.15 in after-hours trading Monday.

BioNexus Gene Lab has named Chong Set Fui as chief financial officer and principal financial officer, effective immediately. Fui succeeds acting CFO and principal financial officer Su-Leng Tan Lee, ...

As the company FDX prepares to report fourth-quarter results after the close Tuesday, that economy has only gotten less ...